Date Of Publication: October 01, 2025
Tags: Briefing, Antimicrobial
Author:ASLM, WHO
Co-authors: ""
Views: 7
Type: Publications for Diagnostics, Articles, Other
Languages: English
Country: South Africa
Antimicrobial resistance (AMR) severely undermines progress against HIV, tuberculosis (TB), and malaria by increasing the risk of treatment failure, mortality, and health system costs due to resistant bacterial and fungal co-infections. By integrating AMR surveillance and laboratory strengthening activities into Global Fund grant proposals countries can support more effective HIV, TB, and malaria disease programs and improve readiness for emerging infectious threats.
